Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.

about

Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.

Item

http://www.wikidata.org/entity/Q46430242

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.

@en

Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.

@nl

type

Item

label

Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.

@en

Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.

@nl

prefLabel

Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.

@en

Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.

@nl

P1476

Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.

@en

P2093

Abdelbasset A Farahat

http://www.w3.org/2001/XMLSchema#string

April C Joice

http://www.w3.org/2001/XMLSchema#string

David W Boykin

http://www.w3.org/2001/XMLSchema#string

Heidi Meeds

http://www.w3.org/2001/XMLSchema#string

Junan Li

http://www.w3.org/2001/XMLSchema#string

Karl A Werbovetz

http://www.w3.org/2001/XMLSchema#string

Mei Feng

http://www.w3.org/2001/XMLSchema#string

Michael Zhuo Wang

http://www.w3.org/2001/XMLSchema#string

P2860

An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

Highly effective oral amphotericin B formulation against murine visceral leishmaniasis

Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans

Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans

CYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovani

Identification of new antileishmanial leads from hits obtained by high-throughput screening

Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi

Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

P31

scholarly article

P356

10.1128/AAC.01129-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sihyung Yang

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29061761

http://www.w3.org/2001/XMLSchema#string

P932

5740383

http://www.w3.org/2001/XMLSchema#string